IT7822421A0 - Cicloalchiltriazoli. - Google Patents

Cicloalchiltriazoli.

Info

Publication number
IT7822421A0
IT7822421A0 IT7822421A IT2242178A IT7822421A0 IT 7822421 A0 IT7822421 A0 IT 7822421A0 IT 7822421 A IT7822421 A IT 7822421A IT 2242178 A IT2242178 A IT 2242178A IT 7822421 A0 IT7822421 A0 IT 7822421A0
Authority
IT
Italy
Prior art keywords
cycloalkyltriazoles
Prior art date
Application number
IT7822421A
Other languages
English (en)
Other versions
IT1094076B (it
Inventor
Silvestrini Bruno
Baiocchi Leandro
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of IT7822421A0 publication Critical patent/IT7822421A0/it
Priority to IT22421/78A priority Critical patent/IT1094076B/it
Priority to CH268579A priority patent/CH639847A5/it
Priority to IL56926A priority patent/IL56926A/xx
Priority to US06/025,273 priority patent/US4252721A/en
Priority to NLAANVRAGE7902489,A priority patent/NL186635C/xx
Priority to AU45832/79A priority patent/AU520788B2/en
Priority to YU862/79A priority patent/YU41338B/xx
Priority to SI7910862A priority patent/SI7910862A8/sl
Priority to GB7912875A priority patent/GB2020269B/en
Priority to FR7909229A priority patent/FR2423221A1/fr
Priority to FI791217A priority patent/FI66378C/fi
Priority to DE19792915318 priority patent/DE2915318A1/de
Priority to MX10123379U priority patent/MX6121E/es
Priority to PT69502A priority patent/PT69502A/pt
Priority to SE7903327A priority patent/SE437663B/sv
Priority to SU792753553A priority patent/SU852174A3/ru
Priority to CA325,782A priority patent/CA1104567A/en
Priority to HU79AI284A priority patent/HU179917B/hu
Priority to DK156779A priority patent/DK148480C/da
Priority to BG043291A priority patent/BG40654A3/xx
Priority to AT0292479A priority patent/AT374477B/de
Priority to PL1979214969A priority patent/PL116103B1/pl
Priority to JP54048519A priority patent/JPS5817757B2/ja
Priority to IE646/79A priority patent/IE47965B1/en
Priority to US06/182,428 priority patent/US4307096A/en
Priority to US06/182,426 priority patent/US4307095A/en
Priority to US06/182,424 priority patent/US4325952A/en
Priority to AT305982A priority patent/AT380251B/de
Application granted granted Critical
Publication of IT1094076B publication Critical patent/IT1094076B/it
Priority to HR940112A priority patent/HRP940112B1/xx
Priority to BG098586A priority patent/BG61367B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT22421/78A 1978-04-18 1978-04-18 Cicloalchiltriazoli IT1094076B (it)

Priority Applications (30)

Application Number Priority Date Filing Date Title
IT22421/78A IT1094076B (it) 1978-04-18 1978-04-18 Cicloalchiltriazoli
CH268579A CH639847A5 (it) 1978-04-18 1979-03-22 Cicloalchiltriazoli.
IL56926A IL56926A (en) 1978-04-18 1979-03-22 Phenyl piperazinyl-tetrahydro-s-triazolo(4,3-a)pyridine azepine)derivatives and process for obtaining same
US06/025,273 US4252721A (en) 1978-04-18 1979-03-29 Cycloalkyltriazoles and process for obtaining same
NLAANVRAGE7902489,A NL186635C (nl) 1978-04-18 1979-03-30 3-(4-fenyl-1-piperazinylalkyl) s-triazolo (4.3-a) azacycloalkanen met farmacologische werking, alsmede werkwijzen ter bereiding van deze verbindingen en farmaceutisch preparaat, bevattende deze verbindingen.
AU45832/79A AU520788B2 (en) 1978-04-18 1979-04-09 Cycloalkyltriazoles
YU862/79A YU41338B (en) 1978-04-18 1979-04-11 Process for obtaining cycloalkyl triazoles
SI7910862A SI7910862A8 (sl) 1978-04-18 1979-04-11 Postopek za pridobivanje cikloalkil-triazola
GB7912875A GB2020269B (en) 1978-04-18 1979-04-11 Cycloalkylatriazoles and process for obtaining same
FR7909229A FR2423221A1 (fr) 1978-04-18 1979-04-11 Cycloalcoyltriazoles pharmaceutiquement utilisables et procedes pour leur obtention
FI791217A FI66378C (fi) 1978-04-18 1979-04-12 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3-(3-(4-aryl-1-piperazinyl)-alkyl)-5,6,7,8-tetrahydro-s-triazolo-(4,3-a)pyridin eller -azepin
DE19792915318 DE2915318A1 (de) 1978-04-18 1979-04-14 Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
MX10123379U MX6121E (es) 1978-04-18 1979-04-16 Procedimiento para la preparacion de derivados de 3,4-cicloalquil triazoles
SE7903327A SE437663B (sv) 1978-04-18 1979-04-17 Cykloalkyltriazoler och forfarande for framstellning derav
PT69502A PT69502A (en) 1978-04-18 1979-04-17 Cycloalkyltriazoles and process for obtaining same
SU792753553A SU852174A3 (ru) 1978-04-18 1979-04-17 Способ получени циклоалкилтри-АзОлОВ или иХ СОлЕй
CA325,782A CA1104567A (en) 1978-04-18 1979-04-17 Cycloalkyltriazoles and process for obtaining same
HU79AI284A HU179917B (en) 1978-04-18 1979-04-17 Process for preparing pyridino- and azepino-triazole derivatives
DK156779A DK148480C (da) 1978-04-18 1979-04-17 Analogifremgangsmaade til fremstilling af cycloalkyltriazoler
JP54048519A JPS5817757B2 (ja) 1978-04-18 1979-04-18 シクロアルキルトリアゾ−ル類およびその製法
AT0292479A AT374477B (de) 1978-04-18 1979-04-18 Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
PL1979214969A PL116103B1 (en) 1978-04-18 1979-04-18 Process for preparing novel derivatives of 3,4-cycloalkyltriazoles
BG043291A BG40654A3 (en) 1978-04-18 1979-04-18 Method for preparing cycloalkyltriazoles
IE646/79A IE47965B1 (en) 1978-04-18 1979-08-08 Cycloalkyltriazoles and process for obtaining same
US06/182,428 US4307096A (en) 1978-04-18 1980-08-29 Method of treating glaucoma with cycloalkyltriazoles
US06/182,426 US4307095A (en) 1978-04-18 1980-08-29 Method of treating schizophrenia with cycloalkltriazoles
US06/182,424 US4325952A (en) 1978-04-18 1980-08-29 Method of treating abstinence syndrome with cycloaklyltriazoles
AT305982A AT380251B (de) 1978-04-18 1982-08-10 Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
HR940112A HRP940112B1 (en) 1978-04-18 1994-02-15 Process for the preparation of cycloalkyl triazoles
BG098586A BG61367B2 (bg) 1978-04-18 1994-02-25 Циклоалкилтриазоли

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22421/78A IT1094076B (it) 1978-04-18 1978-04-18 Cicloalchiltriazoli

Publications (2)

Publication Number Publication Date
IT7822421A0 true IT7822421A0 (it) 1978-04-18
IT1094076B IT1094076B (it) 1985-07-26

Family

ID=11196066

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22421/78A IT1094076B (it) 1978-04-18 1978-04-18 Cicloalchiltriazoli

Country Status (22)

Country Link
US (2) US4252721A (it)
JP (1) JPS5817757B2 (it)
AT (1) AT374477B (it)
AU (1) AU520788B2 (it)
BG (2) BG40654A3 (it)
CA (1) CA1104567A (it)
CH (1) CH639847A5 (it)
DE (1) DE2915318A1 (it)
DK (1) DK148480C (it)
FI (1) FI66378C (it)
FR (1) FR2423221A1 (it)
GB (1) GB2020269B (it)
HU (1) HU179917B (it)
IE (1) IE47965B1 (it)
IL (1) IL56926A (it)
IT (1) IT1094076B (it)
NL (1) NL186635C (it)
PL (1) PL116103B1 (it)
PT (1) PT69502A (it)
SE (1) SE437663B (it)
SU (1) SU852174A3 (it)
YU (1) YU41338B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
FR2580648B1 (fr) * 1985-04-17 1987-05-15 Adir Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4879294A (en) * 1988-01-28 1989-11-07 Angelini Pharmaceuticals Ltd. Opthalmic composition
IT1224250B (it) * 1988-06-10 1990-09-26 Acraf Associzione del depiprazolo con la morfina
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
US5288759A (en) * 1992-08-27 1994-02-22 Alcon Laboratories, Inc. Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
WO2003004058A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
DE602006003416D1 (de) * 2005-03-21 2008-12-11 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
JP2009504628A (ja) * 2005-08-10 2009-02-05 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020087021A1 (en) 2018-10-26 2020-04-30 Ocuphire Pharma, Inc. Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913454A (en) * 1956-11-23 1959-11-17 Schenley Ind Inc Certain cycloalkanotriazoles, process and intermediates
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US3472853A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((pyrido(2,1-c)-s-triazolyl)-lower-alkyl)-4-substituted- piperazines
JPS5070389A (it) * 1973-10-30 1975-06-11

Also Published As

Publication number Publication date
FR2423221A1 (fr) 1979-11-16
YU41338B (en) 1987-02-28
FI791217A (fi) 1979-10-19
JPS5817757B2 (ja) 1983-04-09
YU86279A (en) 1983-12-31
DK156779A (da) 1979-10-19
FI66378B (fi) 1984-06-29
NL186635C (nl) 1991-01-16
GB2020269A (en) 1979-11-14
BG61367B2 (bg) 1997-06-30
IL56926A0 (en) 1979-05-31
AU4583279A (en) 1979-10-25
FR2423221B1 (it) 1983-03-18
SE437663B (sv) 1985-03-11
CH639847A5 (it) 1983-12-15
HU179917B (en) 1983-01-28
AU520788B2 (en) 1982-02-25
DK148480C (da) 1985-12-16
DE2915318C2 (it) 1990-12-13
PL116103B1 (en) 1981-05-30
DE2915318A1 (de) 1979-10-31
IE790646L (en) 1979-10-18
FI66378C (fi) 1984-10-10
GB2020269B (en) 1982-06-03
US4307095A (en) 1981-12-22
PL214969A1 (it) 1980-03-10
IL56926A (en) 1983-09-30
SU852174A3 (ru) 1981-07-30
US4252721A (en) 1981-02-24
SE7903327L (sv) 1979-10-19
JPS54157576A (en) 1979-12-12
PT69502A (en) 1979-05-01
ATA292479A (de) 1983-09-15
NL7902489A (nl) 1979-10-22
BG40654A3 (en) 1987-01-15
DK148480B (da) 1985-07-15
IT1094076B (it) 1985-07-26
AT374477B (de) 1984-04-25
NL186635B (nl) 1990-08-16
CA1104567A (en) 1981-07-07
IE47965B1 (en) 1984-08-08

Similar Documents

Publication Publication Date Title
IT7822421A0 (it) Cicloalchiltriazoli.
FI782916A (fi) Tubformningsfoerfarande.
NL7900354A (nl) Spirothienohydantoinen.
NL7903106A (nl) Granaat.
FI841359A0 (fi) Fenyl-kinolizidiner.
DK429179A (da) 2-propyl-pent-4-en-1-al.
FI77070B (fi) Duscharmatur.
ES238149Y (es) Caja-archivador.
ES235084Y (es) Casquillo-cojinete.
ES234701Y (es) Colchon-butaca.
FI77955B (fi) Anpassningsfilter.
ES233853Y (es) Burlete.
ES234776Y (es) Caja-envase.
ES234952Y (es) Rinconera.
FI83890B (fi) Oevertryckslipmaskin.
ES235019Y (es) Muneco dormilon.
ES233621Y (es) Sofa-cama-nido-litera.
ES233241Y (es) Chupete-masticador.
ES234203Y (es) Caja-estuche.
ES238454Y (es) Servilleta-mantel.
ES236858Y (es) Caja-embalaje.
ES237373Y (es) Porta-esquies.
ES238727Y (es) Estufa-hogar.
ES236556Y (es) Expositor-expendedor.
ES240424Y (es) Baca-caravana.

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 30

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 30, 19920211; AZIENDE CHIMICHE RIUNITE ANGELINI F RANCESCO

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970416